Candriam Equities L Oncology Impact I/  LU1864482515  /

Fonds
NAV15.05.2024 Zm.+14,5801 Typ dystrybucji dochodów Kategoria Firma inwestycyjna
2 253,8301GBP +0,65% z reinwestycją Akcje Candriam 
     
Chart for Candriam Equities L Oncology Impact I
  Nazwa   ISIN Wyniki Zmienność Wskaźnik Sharpe'a
1. BGF World Healthscience I2 JPY LU2263536315 +27,13% 13,29% 1,75
2. JPM Global Healthcare X (acc) - JPY LU0942618132 +24,41% 13,74% 1,50
3. HSBC GLOBAL INVESTMENT FUNDS - GLOBAL EQUITY SUSTAINABLE HEALTHCARE XCEUR LU2350756875 +18,51% 13,05% 1,13
4. KBC Equity Fund We Care Responsible Investing Classic Shares K&H HUF BE6323644201 +16,33% 13,39% 0,94
5. Fidelity Fd.S.Health C.Fd.A Acc HUF LU1273508686 +16,84% 12,68% 1,03
6. HSBC GLOBAL INVESTMENT FUNDS - GLOBAL EQUITY SUSTAINABLE HEALTHCARE ACEUR LU2350756529 +17,21% 13,04% 1,03
7. KBC Equity Fund - Medical Technologies Classic BE0170813936 +14,29% 11,10% 0,95
8. AB SICAV I Int.Health Care Pf.A SGD LU0289739699 +14,23% 10,46% 0,99
9. Manulife Global Fund Healthcare Fund I3 USD LU2089989946 +14,11% 10,91% 0,94
10. AB SICAV I International Health Care Portfolio Class I LU0251855366 +14,27% 10,81% 0,97
...
244. Candriam Equities L Oncology Impact I LU1864482515 +4,88% 11,57% 0,09